Journal of Pharmaceutical Health Care and Sciences 8(1) 2022年12月 [査読有り]
<title>Abstract</title><sec>
<title>Background</title>
Voriconazole (VRCZ) is the first-line therapy for chronic pulmonary aspergillosis and is available in both intravenous and oral formulations. The bioavailability of the oral form is estimate...
Marcia S C Melhem   Vivian C Coelho   Claudia A Fonseca   Lidiane de Oliveira   Lucas X Bonfietti   Maria W Szeszs   Marcello M C Magri   Francine S Dorneles   Hideaki Taguchi   Daniel V S Moreira   Adriana L Motta   Marjorie V Batista   Katsuhiko Kamei   Maria A Shikanai-Yasuda   
Pharmaceutics 14(10) 2161 2022年10月 [査読有り]
Aspergillosis is an invasive fungal disease associated with high mortality. Antifungal susceptibility testing (AFST) is receiving increasing consideration for managing patients, as well as for surveilling emerging drug resistance, despite having t...